Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Veru Inc

Start price
Target price
Perf. (%)
€9.15
15.12.20
€6.00
15.12.21
-18.03%
29.01.21

Capable Management
Good culture
Probably not worthwhile Investment
Few uniques
buy
Phio Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€25.44
14.12.20
€36.00
24.53%
11.01.21

Could be worthwhile Investment >10% per year
buy
Inpixon

Start price
Target price
Perf. (%)
€64.50
14.12.20
€150.00
6.98%
11.01.21

Could be worthwhile Investment >10% per year
buy
TOP Ships Inc.

Start price
Target price
Perf. (%)
€20.80
14.12.20
€40.00
28.85%
11.01.21

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
Halliburton Co.

Start price
Target price
Perf. (%)
€16.52
14.12.20
-
14.12.21
21.50%
15.03.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
ASML Holding N.V. ADR

Start price
Target price
Perf. (%)
€378.00
14.12.20
€510.00
22.22%
18.03.21

Capable Management
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Small cyclical dependencies
buy
ASML Holding N.V. ADR

Start price
Target price
Perf. (%)
€378.00
14.12.20
€510.00
22.22%
18.03.21

Capable Management
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Small cyclical dependencies
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€499.50
14.12.20
€650.00
14.12.21
21.32%
13.05.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€499.50
14.12.20
€650.00
14.12.21
21.32%
13.05.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€499.50
14.12.20
€650.00
14.12.21
21.32%
13.05.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€133.52
14.12.20
€170.00
14.12.21
7.26%
22.04.21

Capable Management
Medium risks for its business
Small cyclical dependencies
Could be very worthwhile Investment >20% year
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€3.06
13.12.20
-
13.12.21
1.50%
11.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Hensoldt AG

Start price
Target price
Perf. (%)
€13.99
13.12.20
-
13.12.21
-11.94%
14.12.21

Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Alico Inc

Start price
Target price
Perf. (%)
€25.80
13.12.20
-
13.12.21
13.95%
14.12.21

Risky Investment
buy
Nanostr.technol.

Start price
Target price
Perf. (%)
€57.50
13.12.20
-
13.12.21
-41.91%
14.12.21

Risky Investment
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
buy
Xcel Energy Inc.

Start price
Target price
Perf. (%)
€53.50
13.12.20
-
13.12.21
11.29%
14.12.21

Risky Investment
buy
Xcel Energy Inc.

Start price
Target price
Perf. (%)
€53.50
13.12.20
-
13.12.21
11.29%
14.12.21

Risky Investment
buy
Xcel Energy Inc.

Start price
Target price
Perf. (%)
€53.50
13.12.20
-
13.12.21
11.29%
14.12.21

Risky Investment
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Ebix Inc.

Start price
Target price
Perf. (%)
€30.20
13.12.20
€35.00
13.12.21
-12.98%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
E.ON SE

Start price
Target price
Perf. (%)
€8.97
13.12.20
-
-0.76%
14.12.20

Could be worthwhile Investment >10% per year
Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand